Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anticoagulant/nekroos

Link salvestatakse lõikelauale
Leht 1 alates 921 tulemused

Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Skin necrosis is a rare but debilitating complication of treatment with vitamin K antagonist anticoagulants such as warfarin. A clinically similar syndrome has been reported less frequently with heparin therapy. We recently managed a thirty-year-old female patient who developed skin necrosis on her
OBJECTIVE Unfractionated heparin is frequently used as an anticoagulant during blood sampling and in cell culture experiments. In the present study we investigated whether heparin and other anticoagulants (citrate and EDTA) interfered with measurements of plasma tumor necrosis factor alpha (TNF
Two cases of necrosis of skin and subcutaneous tissues in patients taking oral anticoagulants are reported, and the English literature is reviewed. The mechanism of coumarin necrosis remains unknown. Most patients are women and the lesions are most common on the abdomen, buttocks, thighs, and

[Skin necrosis with vitamin K antagonists: An imbalance between coagulant and anticoagulant factors].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Skin necrosis with vitamin k antagonists are rare. They affect more frequently middle-aged and obese women, often within 10 days after initiating of treatment. They occur most often in a context of thrombophilia. METHODS An 18-year-old obese woman was treated with heparin and fluindione

Skin necrosis during oral anticoagulant long-term treatment: an atypical side.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The effectiveness of anticoagulant therapy for venous thromboembolism, with regards to both acute phase and long term prophylaxis, in patients with recurrent deep venous thrombosis (DVT) and persistence of risk factors, has been confirmed by many studies. However, it is not free of complications

[Coumarin-induced necrosis--a rare complication of oral anticoagulant therapy].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Coumarin-induced skin necrosis represents a clinical entity that occurs very rarely, with an approximate incidence of 0.01-0.1% at patients following oral anticoagulant therapy. Most of the cases become clinical manifest between the 3rd and 6th of anticoagulant treatment (there were reports of late

Cutaneous necrosis associated with the lupus anticoagulant.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Extensive cutaneous necrosis of the limbs with sudden onset was observed in 3 women suffering from benign systemic lupus erythematosus. All 3 had a circulating anticoagulant and a positive venereal diseases reference laboratory test without anticardiolipin antibodies. They were successfully treated

Warfarin skin necrosis: recurrence in the absence of anticoagulant therapy.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Skin necrosis is a well-known yet rare complication of oral anticoagulant therapy. We report the unusual recurrence of lesions typical of warfarin skin necrosis in the absence of anticoagulant therapy. A 59-year-old woman developed skin necrosis while receiving prophylactic warfarin following the

Effect of anticoagulants and heat on the detection of tumor necrosis factor in murine blood.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Assays for tumor necrosis factor (TNF) may be inhibited by nonspecific factors present in body fluids. We found that the ability to quantitate TNF is greatly affected by blood processing methods. Mice were anesthetized by inhalation of methoxyflurane before obtaining blood by cardiac puncture. The

[Cutaneous necrosis of the breast: a complication of oral anticoagulant treatment].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Cutaneous necrosis of the breast is a rare complication of oral antivitamin K drugs. It occurs shortly after instituting therapy with well-limited, irreversible skin necrosis developing rapidly. The scar is superficial and only involves the subcutaneous tissue; early and extensive surgery does not
The effect of lupus anticoagulant (LA) positive plasma on the expression of human monocyte procoagulant activity (PCA) was studied. LA positive plasma were able to enhance the endotoxin or TNF alpha induced monocyte associated PCA. The monocyte PCA had the characteristic of tissue factor activity

Heparin necrosis: an anticoagulant-induced cutaneous infarct.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A rare complication of subcutaneous heparin therapy is reported in a 75-year-old man. Large erythematous tender plaque developed in the skin overlying the injection sites. In one area of the abdomen, frank necrosis occurred with subsequent eschar formation. Skin testing with five brands of heparin

Necrosis of the breast: a rare complication of anticoagulant therapy.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Protein C and the development of skin necrosis during anticoagulant therapy.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge